CIPLA Ltd is recently witnessing sharp selling pressure from higher levels around Rs.650 because company’s Q2 profits missed the analysts expectations. Net profit decline to Rs. 377cr down by analyst expectations of Rs.390 cr. Net sales decline by 2% to Rs. 4011 cr vs expectation of Rs. 4290 cr.
Visit our website daily for best share tips for tomorrow on stocks listed on National Stock Exchange of India. Subscription plan starts as low as Rs. 2300/- for 1 month. Visit link to see price plans.
As per latest news on Cipla Ltd on 20th May 2019. Share price of Cipla gained by over 2% on zero observation for indore facilityby USFDA. United States Food and Drug Administraion conducted a post-approval inspection at company’s Indore facility from May 13 to May 17, 2019 and the said inspection ended with zero observations.